Metabolic Syndrome Can Be Reduced By Care
Posted on: Friday, 28 April 2006, 15:00 CDT
A multidisciplinary clinical approach to caring for obese patients with metabolic syndrome could lower their heart-disease risk, say U.S. researchers.
Researchers at the Medical College of Wisconsin in Milwaukee found that such care could lower their 10-year risk for cardiovascular disease by nearly 20 percent within six months.
This study highlights the benefits of a clinic that specializes in the needs of obese patients with metabolic syndrome says Dr. Safak Guven, clinical director of the Obesity/Metabolic Syndrome Clinic at Froedtert Hospital in Milwaukee.
Metabolic syndrome affects approximately 24 percent of the U.S. adult population; according to the Third National Health and Nutrition Examination Survey criteria. Metabolic syndrome -- without type 2 diabetes -- significantly increases the risk of coronary heart disease.
Metabolic syndrome occurs in abdominally obese, insulin-resistant patients, with or without type 2 diabetes, and having any of several conditions, including: cholesterol abnormalities, hypertension, clotting, or inflammatory protein factors in their blood.
Guven presented the findings at the American Association of Clinical Endocrinologists Annual Meeting in Chicago.
Source: United Press International
Related Articles
- 8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds
- MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation
- MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
- Mercy Merced Medical Center Selects Clinical Xpert CareFocus From Thomson Reuters for Identification of High-Risk Patients
- Aldagen Announces Initiation of ALD-101 Phase III Trial for Improving Cord Blood Transplants in Pediatric Patients With Inherited Metabolic Diseases
- ACTOS(R) (Pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes
- Metabolex and Ortho-McNeil Forge Metabolic Diseases Pact
- Short-Term and Long-Term Effects of Nasal Intermittent Positive Pressure Ventilation in Patients With Obesity-Hypoventilation Syndrome*
- Research and Markets: Diabetes, Metabolic Syndrome & Cardiovascular Disease: Reshaping Tomorrow's Diabetes Market
- Research and Markets: Business Opportunities in Diabetes, Obesity and Metabolic Disease Market Analysed
 |
 |
User Comments (0)
RSS Feeds